日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea

一种新型的血红蛋白SC疾病小鼠模型揭示了羟基脲发挥有益作用的潜在机制

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024028136
Setayesh, Tahereh; Chi, Mengna; Oestreicher, Zachery; Sakabe, Masahide; Seu, Katie; Zhu, Zhenqi; Kaur, Harsimran; Tijani, Anifat; Xin, Mei; Shova, Amy; Greis, Kenneth D; Townes, Tim M; Balla, József; VandenHeuvel, Katherine; Hu, Yueh-Chiang; Malik, Punam
发表日期：2025
文献求助 收藏

Utilization of insecticide-treated nets and associated factors among childbearing women in Northern Nigeria

尼日利亚北部育龄妇女使用杀虫剂处理蚊帐的情况及其相关因素

期刊:Malaria Journal
影响因子:3
doi:10.1186/s12936-023-04620-4
Solanke, Bola Lukman; Soladoye, Daniel Alabi; Birsirka, Ibrahim Adamu; Abdurraheem, Anifat; Salau, Omowumi Romoke
发表日期：2023
文献求助 收藏

Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer

早期非小细胞肺癌嵌合转录本的全基因组检测

期刊:Cancer Genomics & Proteomics
影响因子:2.6
doi:10.21873/cgp.20394
Ilnytskyy, Yaroslav; Petersen, Lars; McIntyre, John B; Konno, Mie; D'Silva, Adrijana; Dean, Michelle; Elegbede, Anifat; Golubov, Andrey; Kovalchuk, Olga; Kovalchuk, Igor; Bebb, Gwyn
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort

克唑替尼治疗ROS1重排非小细胞肺癌的真实世界管理和结果：一项加拿大回顾性队列研究

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29030160
Gibson, Amanda J W; Box, Adrian; Cheung, Winson Y; Dean, Michelle L; Elegbede, Anifat A; Hao, Desiree; Pabani, Aliyah; Sangha, Randeep; Bebb, Dafydd Gwyn
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors

ALK重排肺癌患者接受ALK受体酪氨酸激酶抑制剂治疗的回顾性真实世界结果

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2021.100157
Gibson, Amanda J W; Box, Adrian; Dean, Michelle L; Elegbede, Anifat A; Hao, Desiree; Sangha, Randeep; Bebb, D Gwyn
肺癌
肿瘤
肿瘤免疫
信号转导
ALK
发表日期：2021
文献求助 收藏

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

加拿大一项关于阿特珠单抗联合铂类-依托泊苷化疗治疗广泛期小细胞肺癌患者的真实世界评估

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2021.100249
Elegbede, Anifat A; Gibson, Amanda J; Fung, Andrea S; Cheung, Winson Y; Dean, Michelle L; Bebb, D Gwyn; Pabani, Aliyah
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC

肿瘤特异性ATM蛋白表达缺失是早期切除的非小细胞肺癌的独立预后因素。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.16215
Petersen, Lars F; Klimowicz, Alexander C; Otsuka, Shannon; Elegbede, Anifat A; Petrillo, Stephanie K; Williamson, Tyler; Williamson, Chris T; Konno, Mie; Lees-Miller, Susan P; Hao, Desiree; Morris, Don; Magliocco, Anthony M; Bebb, D Gwyn
肺癌
肿瘤
肿瘤免疫
ATM
细胞生物学
发表日期：2017
文献求助 收藏

Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines

胃癌细胞系中 ATM 蛋白表达低和 p53 耗竭与奥拉帕尼敏感性相关

期刊:Cell Cycle
影响因子:3.4
doi:10.4161/cc.29212
Eiji Kubota, Christopher T Williamson, Ruiqiong Ye, Anifat Elegbede, Lars Peterson, Susan P Lees-Miller, D Gwyn Bebb
肿瘤
胃癌
肿瘤细胞
发表日期：2014
文献求助 收藏